From patient centered risk factors to comprehensive prognostic models: a suggested framework for outcome prediction

Roni Shouval1,2, Arnon Nagler1,3

  • 1Hematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Insights

Identifying adult patients who benefit most from umbilical cord blood transplantation (UCBT) is crucial. This review examines patient risk factors and proposes a framework for predictive models to improve UCBT outcomes.

Area of Science:

  • Hematology
  • Transplantation Medicine
  • Biostatistics

Background:

  • Optimizing patient selection for umbilical cord blood transplantation (UCBT) is essential for maximizing therapeutic benefits and minimizing risks.
  • Current prognostic models for UCBT outcomes are limited, particularly concerning patient-specific factors.

Purpose of the Study:

  • To review the prognostic significance of patient-related risk factors in adult UCBT recipients.
  • To propose a framework for developing predictive models for UCBT outcomes by integrating patient features.

Main Methods:

  • Systematic literature review focusing on patient-related risk factors in adult UCBT.
  • Conceptual framework development for prognostic model construction.

Main Results:

  • Identified key patient-related risk factors influencing UCBT outcomes.
  • Highlighted the need for comprehensive prognostic models tailored to UCBT.

Conclusions:

  • Patient-specific factors play a critical role in UCBT success.
  • Developing integrated prediction models can enhance patient selection, optimize UCBT processes, and guide future research and interventions.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805